Quantcast

Latest Cylex Inc. Stories

2010-12-14 08:00:00

COLUMBIA, Md., Dec. 14, 2010 /PRNewswire/ -- Cylex Incorporated® today announced that the Centers for Medicare and Medicaid Services (CMS) nearly tripled the reimbursement for ImmuKnow®, the immune cell function assay FDA-cleared for the detection of cell-mediated immune response in populations undergoing immunosuppressive therapy for organ transplant. This significant increase was granted in a time when the overall CMS clinical fee schedule experienced...

2010-03-16 08:00:00

COLUMBIA, Md., March 16 /PRNewswire/ -- Cylex(TM), a global life science company that develops and manufactures in vitro diagnostic products based on patented technology, announced today the expansion of its growing staff with the hiring of Chari-Beth White, Marc Mendels and Julie Fudoli as well as the promotion of James E. "Jim" Brosius. (Logo: http://www.newscom.com/cgi-bin/prnh/20100112/NE34738LOGO ) "Due to the Company's rapid business development and growth in 2009, we are pleased...

2010-03-10 08:00:00

COLUMBIA, Md., March 10 /PRNewswire/ -- Cylex announced today the election of Richard A. ("Dick") Sandberg, founder of DIANON Systems, as an independent director on the Company's board. (Logo: http://www.newscom.com/cgi-bin/prnh/20100112/NE34738LOGO ) Brad L. Stewart, chairman of the board and CEO of Cylex states, "Dick's leadership and achievements in diagnostics are a perfect match for Cylex. With the guidance of Dick and the board, we will continue to build a valuable diagnostics...

2010-02-02 08:00:00

COLUMBIA, Md., Feb. 2 /PRNewswire/ -- Cylex, a leading global life sciences company, announces a revamped corporate image, reflected in its new colors, logo, website (www.cylex.net) and marketing materials. The changes are in keeping with Cylex's dramatic growth over the past five years and recent leadership changes. Cylex is one of the five fastest growing technology, media, telecommunications, life sciences and clean technology companies in the greater Washington D.C. area. (Logo:...

2010-01-12 08:12:00

COLUMBIA, Md., Jan. 12 /PRNewswire/ -- Cylex Incorporated® announced today that the American Medical Association (AMA) CPT Editorial Panel approved the creation of new CPT coding based on the uniqueness, clinical value and widespread use of ImmuKnow, and the fact that existing CPT codes insufficiently captured all steps and costs of testing. (Logo: http://www.newscom.com/cgi-bin/prnh/20100112/NE34738LOGO ) In an effort to keep customers informed of these changes, the...

2009-09-10 08:23:00

COLUMBIA, Md., Sept. 10 /PRNewswire/ -- Cylex, Inc., a venture-backed global life sciences company that develops and manufactures research and in vitro diagnostic products intended to illuminate immunity, announced today the appointment of the company's president, Brad L. Stewart, to chief executive officer and chairman of the board. Since joining Cylex as president in December 2007, Mr. Stewart has successfully led the development of the company's commercial infrastructure, expansion...

2009-04-24 08:45:00

The results of the largest study performed to date will be presented during the International Society for Heart and Lung Transplantation Annual Meeting in Paris, France on April 24, 2009 COLUMBIA, Md., April 24 /PRNewswire/ -- Since it was cleared as an in vitro assessment of cell-mediated immunity in immunosuppressed patient populations, numerous clinical investigations have contributed to defining the role of the Cylex ImmuKnow assay among recipients of solid organ transplants. (Logo:...

2008-08-28 18:00:51

COLUMBIA, Md., Aug. 28 /PRNewswire/ -- "Cylex, Inc., in association with our Korean distributor, Sun Woo Biotech, is delighted to be able to announce our support for a major, multi-center trial of the ImmuKnow assay for cell-mediated immunity at seven highly respected medical institutions in the Republic of Korea," stated Brad Stewart, president of Cylex. "It is a critical goal for the Company to be able to demonstrate the effectiveness of the ImmuKnow assay in transplant populations of...

2008-08-28 18:00:19

COLUMBIA, Md., Aug. 28 /PRNewswire/ -- In association with its Italian distributors, ADA SRL, Cylex, Inc. today announced that the value of its patented ImmuKnow assay will be investigated in one part of a major, three-part, Italian trial of aspects of immunosuppression in patients undergoing liver transplantation subsequent to hepatitis C virus (HCV)-related cirrhosis of the liver. "Cylex is honored to be working with Prof. Antonio Daniele Pinna, MD, and his colleagues at the University of...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related